LDZA.F Aspen Pharmacare Holdings Limited

Healthcare Pharmaceuticals Frankfurt Exchange
9.25 EUR
Close of Nov 12, 2026
4.48 9.50
Market cap
EUR 4.00B
P/E
-
P/B
0.90x
ROE
3.3%
Dividend yield
1.38%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is LDZA.F undervalued?

Graham number

The Graham number of Aspen Pharmacare Holdings Limited cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Aspen Pharmacare Holdings Limited fundamental analysis

No fundamental analysis for Aspen Pharmacare Holdings Limited yet.

Aspen Pharmacare Holdings Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Aspen Pharmacare Holdings Limited

Aspen Pharmacare Holdings Limited, together with its subsidiaries, operates as a specialty and branded pharmaceutical company in Africa, the Middle East, Europe, CIS, Australasia, Asia, and the Americas. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers sterile products in injectable form primarily administered in hospitals and prescribed and administered by physicians or in a retail pharmacy environment for therapeutic areas, such…

Full company profile